methylprednisolone has been researched along with naloxone in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 21 (33.33) | 18.7374 |
1990's | 22 (34.92) | 18.2507 |
2000's | 10 (15.87) | 29.6817 |
2010's | 10 (15.87) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Henry, KR | 1 |
Astrup, J | 1 |
Anderson, RJ; Hanigan, WC | 1 |
Bracken, MB | 3 |
Rosner, MJ | 2 |
Beal, JA; Benzel, EC; Hoffpauir, GM; Kesterson, L; Lancon, JA; Thomas, MM | 1 |
Ducker, TB | 1 |
Baskin, DS; Bracken, MB; Collins, WF; Eisenberg, HM; Flamm, E; Holford, TR; Leo-Summers, L; Maroon, J; Shepard, MJ; Young, W | 1 |
Beamer, KC; Daly, T; Vargish, T; Wilson, A | 1 |
Aasen, AO; Pillgram-Larsen, J; Ruud, TE; Stadaas, JO | 2 |
Blight, AR; DeCrescito, V; Flamm, ES; Gruner, JA; Young, W | 1 |
Ekström, BF; Kuenzig, M; Schwartz, SI | 1 |
Beamer, KC; Daly, T; Vargish, T | 1 |
Inoue, Y | 1 |
Bellamy, RF; DeGuzman, LR; Hollenbach, SJ | 1 |
DeCrescito, V; Demopoulos, HB; Flamm, ES; Pietronigro, DD; Tomasula, JJ | 1 |
Almqvist, PM; Ekström, B; Haglund, U; Kuenzig, M; Schwartz, SI | 2 |
Beamer, KC; Vargish, T | 1 |
Forero-Gómez, J; Olvera-Hidalgo, C; Orozco-Veráztegui, O; Torres-Bedoya, MA; Véliz-Pintos, RA | 1 |
Kostowski, W | 1 |
Ganes, EM; Gurll, NJ; Lutz, SA; Reynolds, DG; Vargish, T | 2 |
Weissglas, IS | 1 |
Hughes, GS | 1 |
D'Alessandro, E; D'Amore, P; Micco, P; Valenti, L | 1 |
Løkken, P; Skjelbred, P | 1 |
Chiu, RC; Hinchey, EJ; Weissglas, IS | 1 |
Eismont, FJ; Slucky, AV | 1 |
Bracken, MB; Duh, MS; Shepard, MJ; Wilberger, JE | 1 |
Bracken, MB; Shepard, MJ | 1 |
Barré, J; Bertault, R; Gomis, P; Graftieaux, JP | 1 |
Aasen, AO; Naess, F; Roeise, O; Stadaas, JO; Waage, A | 1 |
Bracken, MB; Holford, TR | 1 |
Young, W | 1 |
Ducker, TB; Ellenbogen, RG; Ling, GS; Zeidman, SM | 1 |
Seidl, EC | 2 |
Li, TS; Li, YP; Shen, H; Zhang, QJ; Zhang, W | 1 |
Cheng, H; Qin, HD; Wu, HR; Xu, Y; Zhang, Z | 1 |
Sharma, A | 1 |
9 review(s) available for methylprednisolone and naloxone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Steroids after spinal cord injury.
Topics: Acute Disease; Brain Injuries; Clinical Trials as Topic; Drug Administration Schedule; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Naloxone; Spinal Cord Injuries; Time Factors | 1990 |
[Various pharmacological aspects of the treatment of shock].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Dexamethasone; Epoprostenol; Humans; Methylprednisolone; Naloxone; Nitroprusside; Prostaglandins E, Synthetic; Shock | 1982 |
The role of endogenous opiates in shock: experimental and clinical studies in vitro and in vivo.
Topics: Animals; beta-Endorphin; Cardiovascular System; Drug Synergism; Endorphins; Guinea Pigs; Humans; Methylprednisolone; Myocardial Contraction; Naloxone; Narcotic Antagonists; Shock; Swine | 1983 |
Treatment of acute injury of the cervical spine.
Topics: Adolescent; Adult; Cervical Vertebrae; Diagnostic Imaging; Emergency Medical Services; Female; G(M1) Ganglioside; Humans; Hypothermia, Induced; Lipid Peroxides; Male; Methylprednisolone; Middle Aged; Naloxone; Physical Examination; Pregnatrienes; Resuscitation; Spinal Cord Injuries; Thyrotropin-Releasing Hormone | 1995 |
Secondary injury mechanisms in acute spinal cord injury.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Injury Severity Score; Methylprednisolone; Naloxone; Rats; Spinal Cord Injuries; Time Factors | 1993 |
Clinical applications of pharmacologic therapies for spinal cord injury.
Topics: 4-Aminopyridine; Animals; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Free Radical Scavengers; G(M1) Ganglioside; Glucocorticoids; Humans; Methylprednisolone; Multicenter Studies as Topic; Naloxone; Neuroprotective Agents; Pregnatrienes; Randomized Controlled Trials as Topic; Spinal Cord Injuries; Treatment Outcome | 1996 |
Promising pharmacological agents in the management of acute spinal cord injury.
Topics: Acute Disease; Anti-Inflammatory Agents; Drug Interactions; G(M1) Ganglioside; Humans; Methylprednisolone; Naloxone; Narcotic Antagonists; Neuroprotective Agents; Pregnatrienes; Research Design; Spinal Cord Injuries; Treatment Outcome | 1999 |
Promising pharmacological agents in the management of acute spinal cord injury.
Topics: Acute Disease; Antioxidants; G(M1) Ganglioside; Humans; Methylprednisolone; Naloxone; Narcotic Antagonists; Neuroprotective Agents; Pregnatrienes; Spinal Cord Injuries | 2000 |
14 trial(s) available for methylprednisolone and naloxone
Article | Year |
---|---|
Commentary on NASCIS-2.
Topics: Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Humans; Incidence; Information Services; Mass Media; Methylprednisolone; Naloxone; Odds Ratio; Publishing; Research Design; Spinal Cord Injuries; Time Factors; Truth Disclosure | 1992 |
Pharmacological treatment of acute spinal cord injury: current status and future prospects.
Topics: Follow-Up Studies; Humans; Methylprednisolone; Naloxone; Spinal Cord Injuries | 1992 |
Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial.
Topics: Acute Disease; Double-Blind Method; Humans; Methylprednisolone; Naloxone; Neurologic Examination; Spinal Cord Injuries; Time Factors | 1991 |
Steroids after spinal cord injury.
Topics: Acute Disease; Brain Injuries; Clinical Trials as Topic; Drug Administration Schedule; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Naloxone; Spinal Cord Injuries; Time Factors | 1990 |
Treatment of spinal-cord injury.
Topics: Humans; Methylprednisolone; Multicenter Studies as Topic; Naloxone; Randomized Controlled Trials as Topic; Spinal Cord Injuries | 1990 |
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.
Topics: Acute Disease; Adolescent; Adult; Double-Blind Method; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Motor Activity; Multicenter Studies as Topic; Naloxone; Randomized Controlled Trials as Topic; Sensation; Spinal Cord Injuries; Time Factors | 1990 |
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury.
Topics: Acute Disease; Humans; Methylprednisolone; Naloxone; Proprioception; Public Relations; Spinal Cord Injuries | 1990 |
Naloxone and methylprednisolone sodium succinate enhance sympathomedullary discharge in patients with septic shock.
Topics: Bacteria; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Epinephrine; Heart Rate; Hemodynamics; Humans; Methylprednisolone; Methylprednisolone Hemisuccinate; Naloxone; Norepinephrine; Shock, Septic; Stroke Volume; Vascular Resistance | 1984 |
Effects of naloxone on post-operative pain and steroid-induced analgesia.
Topics: Adrenal Cortex Hormones; Adult; Double-Blind Method; Endorphins; Female; Humans; Male; Methylprednisolone; Naloxone; Pain, Postoperative; Random Allocation; Surgery, Oral | 1983 |
The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment.
Topics: Adolescent; Adult; Combined Modality Therapy; Disability Evaluation; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methylprednisolone; Naloxone; Neurologic Examination; Postoperative Complications; Spinal Cord Injuries; Treatment Outcome | 1994 |
The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. National Acute Spinal Cord Injury Study.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Humans; Liver; Liver Function Tests; Methylprednisolone; Naloxone; Spinal Cord Injuries | 1994 |
Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2.
Topics: Drug Administration Schedule; Humans; Injury Severity Score; Methylprednisolone; Naloxone; Nervous System; Spinal Cord Injuries | 1993 |
Secondary injury mechanisms in acute spinal cord injury.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Injury Severity Score; Methylprednisolone; Naloxone; Rats; Spinal Cord Injuries; Time Factors | 1993 |
Pharmacological treatment of acute spinal cord injury: current status and future projects.
Topics: Adult; Female; Humans; Injury Severity Score; Male; Methylprednisolone; Middle Aged; Motor Activity; Naloxone; Sensation; Spinal Cord Injuries; Time Factors | 1993 |
42 other study(ies) available for methylprednisolone and naloxone
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Noise-induced auditory loss: influence of genotype, naloxone and methyl-prednisolone.
Topics: Animals; Auditory Threshold; Evoked Potentials, Auditory, Brain Stem; Genotype; Hearing Loss, Noise-Induced; Methylprednisolone; Mice; Mice, Inbred CBA; Mice, Inbred Strains; Naloxone | 1992 |
[Prednisolone or naloxone in spinal injuries].
Topics: Acute Disease; Follow-Up Studies; Humans; Methylprednisolone; Naloxone; Spinal Cord Injuries | 1992 |
Methylprednisolone for spinal cord injury.
Topics: Humans; Methylprednisolone; Naloxone; Nervous System; Spinal Cord Injuries | 1992 |
National acute spinal cord injury study of methylprednisolone or naloxone.
Topics: Humans; Methylprednisolone; Naloxone; Randomized Controlled Trials as Topic; Spinal Cord Injuries | 1991 |
Dose-dependent effects of naloxone and methylprednisolone in the ventral compression model of spinal cord injury.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Methylprednisolone; Naloxone; Paraplegia; Rats; Rats, Inbred Strains; Spinal Cord Injuries; Spinal Fractures | 1990 |
Correlation of plasma beta-endorphin levels with mean arterial pressure and cardiac output in hypovolemic shock.
Topics: Animals; beta-Endorphin; Blood Pressure; Cardiac Output; Dogs; Endorphins; Methylprednisolone; Naloxone; Shock | 1987 |
Multitherapy: a new treatment regimen in endotoxemia.
Topics: Animals; Drug Therapy, Combination; Endotoxins; Escherichia coli; Hemodynamics; Kallikreins; Ketanserin; Methylprednisolone; Naloxone; Oxygen; Promethazine; Protease Inhibitors; Shock, Septic; Swine | 1987 |
Hemodynamic consequences of multitherapy pretreatment in experimental endotoxemia.
Topics: Animals; Drug Therapy, Combination; Endotoxins; Escherichia coli; Hemodynamics; Ketanserin; Lipopolysaccharides; Methylprednisolone; Naloxone; Oxygen; Promethazine; Protease Inhibitors; Pulmonary Circulation; Shock, Septic; Swine | 1987 |
Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone.
Topics: Animals; Cats; Dose-Response Relationship, Drug; Drug Combinations; Female; Methylprednisolone; Motor Activity; Naloxone; Paralysis; Spinal Cord Injuries | 1988 |
Pulmonary platelet trapping in Escherichia coli endotoxin-injected dogs treated with methylprednisolone, ibuprofen and naloxone.
Topics: Animals; Blood Platelets; Blood Pressure; Diarrhea; Dogs; Endotoxins; Escherichia coli; Female; Hematocrit; Ibuprofen; Leukocyte Count; Male; Methylprednisolone; Naloxone; Platelet Count; Respiratory Distress Syndrome; Shock, Septic | 1986 |
Late administration of methylprednisolone does not enhance naloxone effect in hypovolemic shock.
Topics: Animals; Dogs; Endorphins; Hemodynamics; Methylprednisolone; Naloxone; Shock | 1986 |
[Evoked spinal potentials in the Wistar rat: effect of cord compression and drugs].
Topics: Animals; Disease Models, Animal; Evoked Potentials; Male; Methylprednisolone; Naloxone; Prostaglandins E; Rats; Rats, Inbred Strains; Spinal Cord; Spinal Cord Compression | 1986 |
Early administration of methylprednisolone promotes survival in rats with intra-abdominal sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cecum; Disease Models, Animal; Drug Administration Schedule; Ligation; Male; Methylprednisolone; Naloxone; Punctures; Rats; Rats, Inbred Strains | 1986 |
Ascorbic acid: a putative biochemical marker of irreversible neurologic functional loss following spinal cord injury.
Topics: Animals; Ascorbic Acid; Cats; Disease Models, Animal; Homeostasis; Locomotion; Methylprednisolone; Naloxone; Paraplegia; Spinal Cord Injuries; Time Factors | 1985 |
Effect of high dose corticosteroids alone or combined with other drugs on survival in septic shock.
Topics: Animals; Dogs; Drug Therapy, Combination; Endotoxins; Humans; Ibuprofen; Methylprednisolone; Naloxone; Shock, Septic | 1985 |
Effect of methylprednisolone on naloxone's hemodynamic response in canine hypovolemic shock.
Topics: Animals; Critical Care; Dogs; Drug Therapy, Combination; Hemodynamics; Methylprednisolone; Naloxone; Shock | 1986 |
[Clinical evaluation of the effect of the administration of naloxone in comparison with methylprednisolone in infants with septic shock].
Topics: Blood Pressure; Body Temperature; Heart Rate; Hematocrit; Humans; Infant; Methylprednisolone; Naloxone; Oxygen; Shock, Septic | 1985 |
The interaction of corticosteroids and naloxone in canine hemorrhagic shock.
Topics: Animals; Dexamethasone; Dogs; Drug Therapy, Combination; Heart; Methylprednisolone; Naloxone; Receptors, Opioid; Shock, Hemorrhagic | 1982 |
Increased survival of endotoxin-injected dogs treated with methylprednisolone, naloxone, and ibuprofen.
Topics: Animals; Blood Cell Count; Blood Pressure; Dogs; Drug Therapy, Combination; Endotoxins; Female; Ibuprofen; Male; Methylprednisolone; Naloxone; Shock, Septic; Time Factors | 1984 |
[The treatment of overdose: clinical experiences].
Topics: Humans; Methylprednisolone; Naloxone; Oxygen Inhalation Therapy; Poisoning | 1983 |
Hemodynamic changes following corticosteroid and naloxone infusion in dogs subjected to hypovolemic shock without resuscitation.
Topics: Adrenal Cortex Hormones; Animals; Dexamethasone; Dogs; Hemodynamics; Methylprednisolone; Naloxone; Shock | 1983 |
Naloxone and methylprednisolone in the treatment of experimental septic shock.
Topics: Animals; Blood Pressure; Cardiac Output; Drug Synergism; Endorphins; Escherichia coli; Lactates; Methylprednisolone; Naloxone; Pulmonary Wedge Pressure; Pyruvates; Shock, Septic; Swine | 1982 |
[Spinal cord injuries and corticotherapy. The NASCIS II study and feasibility].
Topics: Acute Disease; Clinical Trials, Phase II as Topic; Emergencies; Evaluation Studies as Topic; Feasibility Studies; Humans; Methylprednisolone; Naloxone; Spinal Cord Injuries; Time Factors | 1994 |
Effects of a combined drug regimen on tumour necrosis factor and plasma kallikrein activity in experimental endotoxaemia.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Escherichia coli Infections; Hemodynamics; Kallikreins; Ketanserin; Methylprednisolone; Naloxone; Promethazine; Protease Inhibitors; Shock, Septic; Swine; Tumor Necrosis Factor-alpha | 1994 |
[Effects of combined naloxone and methylprednisolone on nuclear factor-kappaB expression in the lung in acute lung injury in rats].
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Interleukin-8; Lipopolysaccharides; Lung; Male; Methylprednisolone; Naloxone; NF-kappa B; Random Allocation; Rats; Rats, Wistar | 2005 |
[Protective effect of methylprednisolone and Naloxone on pulmonary ischemia/reperfusion injury in rats].
Topics: Animals; Apoptosis; Caspase 3; Disease Models, Animal; I-kappa B Proteins; Lung; Male; Methylprednisolone; Naloxone; NF-KappaB Inhibitor alpha; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2008 |
Pharmacological management of acute spinal cord injury.
Topics: Acute Disease; Anti-Inflammatory Agents; Clinical Trials as Topic; Humans; Methylprednisolone; Naloxone; Neuroprotective Agents; Pregnatrienes; Spinal Cord Injuries; Time Factors; Treatment Outcome | 2012 |